The Santa Monica and San Gabriel mountains formed millions of years ago. Within both of them lies a fascinating world of rocks, gemstones, crystals and minerals. Here's how to start identifying them.

Rose quartz is the classic heart stone, and it’s popular for a reason. It’s often used for love intentions, whether you’re ...

Showcased on Beijing’s former imperial grounds, Cartier’s second chapter of its En Équilibre high jewellery collection treads a fine balance between heritage and contemporary relevance ...

Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

If you are looking for a last minute gift for a canna-girl in your life, consider curating a coordinated gift set.

According to Numerology, your moolank is determined by your date of birth and you get one distinctive number that has a ruling planet. Now you must be thinking about how is it necessary to know about ...

Pennsylvania may not be the first place that comes to mind when thinking of gemstone mining, but the Keystone State has a surprising diversity of beautiful natural gemstones that can be found across ...

Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...

BERLIN, Sept 9 (Reuters) - Novartis (NOVN.S), opens new tab will acquire Tourmaline Bio (TRML.O), opens new tab for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion ...

Novartis NOVN-0.45%decrease; red down pointing triangle agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted ...

Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed in a phase 2 study earlier this year. At the center of the deal is ...

– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion – – Transaction reflects the potential of Tourmaline’s pacibekitug, a ...